Richard C. Malabre

Chief Accounting Officer, Akebia Therapeutics, Inc.

Companies

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Feb 2, 2026Sold 13,382 shares at $1.39 of Akebia Therapeutics, Inc.²
Feb 2, 2026Sold 36,142 shares at $1.39 of Akebia Therapeutics, Inc.²
Jan 30, 2026Granted 79,000 shares of Akebia Therapeutics, Inc.³
Jun 9, 2025Sold 15,000 shares at $4.01 of Akebia Therapeutics, Inc.⁴
Jun 9, 2025Exercised options 15,000 shares at $1.68 of Akebia Therapeutics, Inc.⁴
Jun 4, 2025Sold 13,334 shares at $3.53 of Akebia Therapeutics, Inc.⁵
Feb 3, 2025Sold 30,202 shares at $2.10 of Akebia Therapeutics, Inc.⁶
Jan 31, 2025Granted 85,000 shares of Akebia Therapeutics, Inc.⁶
Jan 31, 2024Granted 223,950 shares of Akebia Therapeutics, Inc.⁷

The numbers on this page point here. Each one links to the record it came from.